The intramedullary nails market has seen considerable growth due to a variety of factors.
• The market for intramedullary nails has seen significant growth in past years. It's anticipated to expand from $0.87 billion in 2024 to $0.94 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.5%.
The historic growth can be traced back to an increase in fracture cases, the susceptibility of the aging population, evolution of surgical techniques and technology, a shift towards less invasive surgical methods, and progress in design and material science.
The intramedullary nails market is expected to maintain its strong growth trajectory in upcoming years.
• The intramedullary nails industry is anticipated to experience robust growth in upcoming years, elevating to $1.24 billion by 2029, boasting a compound annual growth rate (CAGR) of 7.2%.
Factors contributing to this growth over the predicted period include an upsurge in sports-related injuries, expanded access to surgical procedures, heightened awareness within healthcare circles, and a rise in outpatient surgical procedures. Key trends within this projected timeframe involve the increased utilization of locking nails, the development and application of bioabsorbable nails, a shift towards personalized medicine, emerging economies increasing access to healthcare, and the incorporation of smart technologies within orthopedic devices.
The rise in bone fracture cases is projected to fuel the development of the intramedullary nails market. A bone fracture is a medical problem marked by a partial or full discontinuity in a bone. It happens when a bone is subjected to force that surpasses its strength and integrity, resulting in it breaking or cracking. Furthermore, osteoporosis is a condition where bones become frail, weak, and fragile due to a reduction in bone density, which makes them more prone to fractures. Intramedullary nails offer internal support by being inserted into the medullary canal of long bones, a procedure necessary for the correct alignment and healing of fractured bones. For example, in February 2023, the Switzerland-based non-governmental organization, International Osteoporosis Foundation, reported that there are as many as 37 million fragility fractures occurring each year in individuals over 55 globally, equivalent to approximately 70 fractures per minute. Consequently, the escalating number of bone fractures is driving the growth of the intramedullary nails market.
The intramedullary nailsmarket covered in this report is segmented –
1) By Type: Long Gamma Nail (LGN), Trochanteric Femoral Nail (TFN), Intertroch/Subtroch Nail (ITST), Other Types
2) By Material: Titanium Alloys, Stainless Steel
3) By Application: Femoral Fracture, Tibial Fracture, Other Applications
4) By End User: Hospitals, Ambulatory Surgical Centers, Specialty And Orthopedic Clinics, Other End User
Subsegments:
1) By Long Gamma Nail (LGN): Standard Long Gamma Nails, Proximal Long Gamma Nails
2) By Trochanteric Femoral Nail (TFN): Standard Trochanteric Femoral Nails, Cephalomedullary Trochanteric Nails
3) By Intertroch/Subtroch Nail (ITST): Intertrochanteric Nails, Subtrochanteric Nails
4) By Other Types: Antegrade Intramedullary Nails, Retrograde Intramedullary Nails, Tibial Intramedullary Nails, Femoral Intramedullary Nails
Leading businesses in the intramedullary nails market are concentrating on the development of innovative products such as hip fracture nailing systems. This is aimed to provide improved stability, better surgical results, and advanced features for minimally invasive procedures. A hip fracture nailing system is a unique surgical instrument used in treating hip fractures specifically in the upper femur area such as intertrochanteric or subtrochanteric fractures. Take for example, September 2022, when Stryker Corporation, a medical technology firm based in the US producing medical instruments, released the Gamma4 Hip Fracture Nailing System. It is the successor of its intramedullary nailing system engineered to handle hip fractures. The Gamma4 System is intended for stable as well as unstable hip fractures that include the intracapsular, trochanteric, subtrochanteric, and shaft areas of the femur. The nail, designed by SOMA, includes length-dependent RoC for long nails, a proximal body reduced by 5mm, a chamfered distal tip, and a pre-inserted and cannulated setting screw.
Major companies operating in the intramedullary nails market are:
• Johnson & Johnson
• Medtronic plc
• Stryker Corporation
• B. Braun Melsungen AG
• Zimmer Biomet Holdings Inc.
• Smith & Nephew plc
• Integra LifeSciences Holdings Corporation
• NuVasive Inc.
• Globus Medical Inc.
• Wright Medical Group N.V.
• Orthofix Medical Inc.
• Aesculap Inc.
• Paragon 28 Inc.
• Acumed LLC
• Alphatec Spine Inc.
• OsteoMed LLC
• Merete Medical GmbH
• Skeletal Dynamics LLC
• Centinel Spine Inc.
• Teijin Nakashima Medical Co. Ltd.
• MICROMED Medizintechnik GmbH
• Orthopaedic Implant Company
• Orthomed S.A.S.
• Novastep Inc.
• BioMedtrix LLC
North America was the largest region in the intramedullary nails market in 2024. The regions covered in the intramedullary nails market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.